IL-1β in bronchial lavage fluid is a non-invasive marker that predicts the viability of the pulmonary graft from the non-heart-beating donor

Journal of Heart and Lung Transplantation

Volumn 24, Issue 1, 2005, Pages 20-28

  Rega, Filip R ^a   Vanaudenaerde, Bart M ^b   Wuyts, Wim A ^b   Jannis, Nicole C ^a   Verleden, Geert M ^b   Lerut, Toni E ^c   Van Raemdonck, Dirk E M ^a,c  

^a Center for Experimental Surgery and Anesthesiology   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; INTERLEUKIN 1; OXYGEN;

AIRWAY PRESSURE; ANIMAL TISSUE; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; COOLING; CORRELATION ANALYSIS; DOMESTIC PIG; GRAFT PATENCY; HEART; HEMODYNAMICS; ISCHEMIA; LIVING DONOR; LUNG; LUNG LAVAGE; NONHUMAN; OXYGENATION; PREDICTION; PRIORITY JOURNAL; REPERFUSION; STATISTICAL SIGNIFICANCE; STORAGE; THORAX DRAINAGE; TREATMENT OUTCOME; VASCULAR RESISTANCE; ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; BODY TEMPERATURE; CHEMISTRY; COMPARATIVE STUDY; EVALUATION; HISTOLOGY; LUNG TRANSPLANTATION; LUNG WEDGE PRESSURE; METABOLISM; ORGAN PRESERVATION; ORGAN SIZE; PHYSIOLOGY; PREDICTION AND FORECASTING; STATISTICS; SWINE;

ANIMALS; BIOLOGICAL MARKERS; BODY TEMPERATURE; BRONCHOALVEOLAR LAVAGE FLUID; INTERLEUKIN-1; LUNG; LUNG TRANSPLANTATION; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; ORGAN PRESERVATION; ORGAN SIZE; OXYGEN; PREDICTIVE VALUE OF TESTS; PULMONARY WEDGE PRESSURE; STATISTICS; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR RESISTANCE;

EID: 11844249269     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.10.004     Document Type: Article

References (32)

1. Egan T.M., Boychuk J.E., Rosato K., Cooper J.D. Whence the lungs? A study to assess suitability of donor lungs for transplantation. Transplantation. 53:1992;420-422
2. Pierre A.F., Sekine Y., Hutcheon M.A., Waddell T.K., Keshavjee S.H. Marginal donor lungs a reassessment. J Thorac Cardiovasc Surg. 123:2002;421-427
3. Artemiou O., Birsan T., Taghavi S., et al. Bilateral lobar transplantation with the split lung technique. J Thorac Cardiovasc Surg. 118:1999;369-370
4. Cohen R.G., Starnes V.A. Living donor lung transplantation. World J Surg. 25:2001;244-250
5. Egan T.M., Lambert C.J. Jr, Reddick R., et al. A strategy to increase the donor pool use of cadaver lungs for transplantation. Ann Thorac Surg. 52:1991;1113-1120
6. Steen S., Sjoberg T., Pierre L., Liao Q., Eriksson L., Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet. 357:2001;825-829
7. Aitchison J.D., Orr H.E., Flecknell P.A., Kirby J.A., Dark J.H. Functional assessment of non-heart-beating donor lungs prediction of post-transplant function. Eur J Cardiothorac Surg. 20:2001;187-194
8. Steen S., Liao Q., Wierup P.N., Bolys R., Pierre L., Sjoberg T. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann Thorac Surg. 76:2003;244-252
9. Krishnadasan B., Naidu B.V., Byrne K., Fraga C., Verrier E.D., Mulligan M.S. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 125:2003;261-272
10. Barnes P.J. Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med. 150:1994;S42-S49
11. Strieter R.M., Kunkel S.L., Showell H.J., et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science. 243:1989;1467-1469
12. Hocking D.C., Phillips P.G., Ferro T.J., Johnson A. Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha. Circ Res. 67:1990;68-77
13. Bevilacqua M.P., Pober J.S., Mendrick D.L., Cotran R.S., Gimbrone M.A. Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A. 84:1987;9238-9242
14. Clark B.D., Bedrosian I., Schindler R., et al. Detection of interleukin 1 alpha and 1 beta in rabbit tissues during endotoxemia using sensitive radioimmunoassays. J Appl Physiol. 71:1991;2412-2418
15. Pugin J., Ricou B., Steinberg K.P., Suter P.M., Martin T.R. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med. 153:1996;1850-1856
16. Steen S., Sjoberg T., Ingemansson R., Lindberg L. Efficacy of topical cooling in lung preservation is a reappraisal due? Ann Thorac Surg. 58:1994;1657-1663
17. Fiser S.M., Kron I.L., McLendon L.S., Kaza A.K., Kern J.A., Tribble C.G. Early intervention after severe oxygenation index elevation improves survival following lung transplantation. J Heart Lung Transplant. 20:2001;631-636
18. D'Armini A.M., Roberts C.S., Griffith P.K., Lemasters J.J., Egan T.M. When does the lung die? I. Histochemical evidence of pulmonary viability after "death" J Heart Lung Transplant. 13:1994;741-747
19. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 346:2002;549-556
20. Curfman G. Hypothermia to protect the brain. N Engl J Med. 346:2002;546
21. Kootstra G., Daemen J.H., Oomen A.P. Categories of non-heart-beating donors. Transplant Proc. 27:1995;2893-2894
22. Rega F.R., Jannis N.C., Verleden G.M., Flameng W.J., Lerut T.E., Van Raemdonck D.E. Should we ventilate or cool the pulmonary graft inside the non-heart-beating donor? J Heart Lung Transplant. 22:2003;1226-1233
23. Rega FR, Neyrinck AP, Verleden GM, Lerut TE, Van Raemdonck DE. How long can we preserve the pulmonary graft inside the non-heart-beating donor? Ann Thorac Surg (in press).
24. Rega F.R., Vandezande E.J., Jannis N.C., Verleden G.M., Lerut T.E., Van Raemdonck D.E. The role of leukocyte depletion in ex vivo evaluation of pulmonary grafts from (non)-heart beating donors. Perfusion. 18:2003;13-21
25. Rega F.R., Jannis N.C., Verleden G.M., Lerut T.E., Van Raemdonck D.E.M. Long-term preservation with interim evaluation of lungs from a non-heart-beating donor after a warm ischemic interval of 90 minutes. Ann Surg. 238:2003;782-792
26. Donnelly S.C., Strieter R.M., Kunkel S.L., et al. Interleukin-8 and the development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 341:1993;643-647
27. Fisher A.J., Donnelly S.C., Hirani N., et al. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet. 353:1999;1412-1413
28. Fisher A.J., Donnelly S.C., Hirani N., et al. Elevated levels of Interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am J Respir Crit Care Med. 163:2001;259-265
29. Eppinger M.J., Jones M.L., Deeb G.M., Bolling S.F., Ward P.A. Pattern of injury and the role of neutrophils in reperfusion injury of rat lung. J Surg Res. 58:1995;713-718
30. Khimenko P.L., Bagby G.J., Fuseler J., Taylor A.E. Tumor necrosis factor-alpha in ischemia and reperfusion injury in rat lungs. J Appl Physiol. 85:1998;2005-2011
31. Van Raemdonck D.E., Jannis N.C., De Leyn P.R., Flameng W.J., Lerut T.E. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg. 228:1998;788-796
32. Greco R., Cordovilla G., Sanz E., et al. Warm ischemic time tolerance after ventilated non-heart-beating lung donation in piglets. Eur J Cardiothorac Surg. 14:1998;319-325